DEC 22, 2016 03:38 PM PST

Negative Link between Malaria Resistance and Cancer Metastasis

WRITTEN BY: Xuan Pham

A mutation that confers resistance to malaria is now linked to cancer metastasis. This finding illustrates evolutionary changes may sometimes be a double-edge sword.

Despite the best efforts, parts of Africa have disproportionately high rates of malaria. For example, more than 90 percent of malarial cases were documented in Sub-Saharan Africa alone. The disease is attributed to a large percentage of deaths.

The high rate of malaria acts as an evolutionary pressure, selecting for individuals with unique mutations that confer resistance to this disease. In particular, people in West Africa and sub-Saharan Africa are more likely to have an alternate version of the Duffy Antigen Receptor (DARC) gene than any other population. The widely prevalent version of the DARC gene “makes most Africans less susceptible to a type of malaria caused by [the parasite] Plasmodium vivax,” said Geoffrey Siwo, a scientist at the IBM Research Africa in Johannesburg.

In studying the interactions between malaria and other diseases, Siwo and his team found a paradoxical, if not tragic, link between the DARC mutation and cancer. Specifically, they found that people who have the DARC variation and are protected from malaria were less likely to survive cancer. In other words, the variation that confers malarial resistance could somehow be helping the spread of cancer.

For the study, Siwo and his team concentrated on breast cancer. According to the International Agency for Research on Cancer (IARC) and World Health Organization, breast cancer rates in Africa range from around 20 per 100,000 women to as high as over 40 per 100,000 women.

"If this variant does play a role in cancer metastasis, it would be an example where a genetic variant which rises to high frequency due to protection from malaria may also be associated with disease risk", said Sarah Tishkoff, a professor at the University of Pennsylvania, who was not associated with the study.

For Siwo though, the cup is half-full. "The knowledge that low expression of DARC might influence breast cancer outcomes, especially in some breast cancer patients means that in future it could potentially be used for personalizing therapy or precision medicine," he says.

Thinking more globally, future research into how the DARC genetic variation could be driving cancer growth may open new avenues for therapy that we’ve yet to uncover.

Additional sources: CNN

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 07, 2018
Cancer
AUG 07, 2018
Can a Myeloid Marker Be Helpful in B-cell Neoplasm Diagnostic Testing?
A group of US researchers have identified CD13 in certain subtypes of B-cell neoplasms, thereby aiding in a more detailed diagnosis....
AUG 21, 2018
Cancer
AUG 21, 2018
Theranostics.....Heard of it?
Theranostics is an emerging field that combines therapeutics and diagnostic capabilities into one opportunity for treatment of diseases, especially cancer....
AUG 29, 2018
Immunology
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
SEP 15, 2018
Clinical & Molecular DX
SEP 15, 2018
Cancer & Anoikis: A Match Not Made in Heaven
Anoikis have always been intimately entwined with cancer, henceforth the quest to seek how they came to be as such....
OCT 03, 2018
Cell & Molecular Biology
OCT 03, 2018
Single Cell Modified in CAR T Therapy Causes Deadly Relapse
One cell meant a very different outcome for a patient that was the recipient of a cutting-edge cancer therapy....
OCT 05, 2018
Cancer
OCT 05, 2018
FDA approves a new drug for an advanced type of skin cancer
As cancer is one of the most challenging diseases in our world, many efforts have been put into researching new ways for treatment to find new drugs that could help more patients worldwide. A...
Loading Comments...